GIVE MISS CALL ON :- +91 99774 99927

CAPITALSTARS- INDIAN EQUITY MARKET OUTLOOK UPDATE – 11 SEPTEMBER 2019

capitalstars-Equity-market-Outlook

Market Live: Nifty likely to open flat.

The Nifty50 is expected to open flat on Wednesday following positive trend seen in other Asian markets as hopes of diminishing U.S.-China tensions and reduced risk of no-deal Brexit lifted sentiment. On Wall Street, the S&P 500 ended little changed as a rally in energy and industrial shares countered a drop in the technology and real-estate sectors with investors favouring value over growth, said a Reuters report. Trends on SGX Nifty indicate a positive opening for the broader index in India, with a 41 points gain or 0.37 percent. Nifty futures were trading around 11,012-level on the Singaporean Exchange. If we compare it with Monday closing of SGX Nifty which was at 11,037, it shows a small downtick of 19 points. Indian market remains shut on Tuesday on account of a public holiday.

Global Market:

Asian Markets: Asian markets are higher today as Chinese and Hong Kong shares show gains. The Shanghai Composite is up 0.34% while the Hang Seng is up 0.65%. The Nikkei 225 is not trading.
US Markets: North and South American markets finished mixed as of the most recent closing prices. The S&P 500 gained 0.03%, while the IPC led the Bovespa lower. They fell 0.17% and 0.14% respectively.
European Markets: European markets finished higher today with shares in London leading the region. The FTSE 100 is up 0.44% while Germany’s DAX is up 0.35% and France’s CAC 40 is up 0.08%.

Major Headlines of the day:

Rupee stands at 71.70 per dollar.

Varun Beverages to acquire 20% stake in Lunarmech Technologies Post acquisition, the company will hold 55% of the effective equity share capital of Lunarmech.

Glenmark Pharma gets ANDA nod for Clobetasol Propionate Foam According to IQVIA sales data for the 12 months ending July 2019, the OluxE Foam, 0.05% market achieved annual sales of approximately $11.1 mn.

Sun Pharma unit raises stake in PJSC Biosintez, Russia Post completion of this purchase of shares, the total holding of the wholly-owned subsidiary company was increased from 96.96% to 100% in PJSC Biosintez, the pharma company said in the filing.

Trend in FII flows:- The FIIs were Net Value of Rs -188.08 segment while the DIIs were Net Value of 686.47 the provisional figures.

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

CapitalStars Investment Adviser: SEBI Registration Number: INA000001647.

Leave a Reply

Checking...

Ouch! There was a server error.
Retry »

Sending message...

FREE TRIAL REQUEST


CapitalStars FORUM